Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

优辉药业（北京）有限公司🇨🇳 National Medical Products Administration

Approval Id: 8nJAtWPjoyL
Approval Number: 国药准字H20255288
Generic Name: 达格列净二甲双胍缓释片(Ⅲ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含达格列净5mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg
Reg Date: 2025-09-02
Company Name: 优辉药业（北京）有限公司
Company Address: 北京市大兴区中关村科技园区大兴生物医药产业基地永兴路29号附属办公楼6层663室
Production Company Name: 北京京丰制药集团有限公司
Production Company Address: 北京市大兴区中关村科技园区大兴生物医药产业基地祥瑞大街21号（9、10、12、13号楼）
Company Detail Path: /organization/you-hui-yao-ye-bei-jing-you-xian-gong-si
Production Company Detail Path: /organization/bei-jing-jing-feng-zhi-yao-ji-tuan-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 2, 2025

Approval ID

8nJAtWPjoyL

Type

化学药品